Special Article
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab
Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab
Read
11265
Timeswas read the article
1661
Total PDF
9604
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 7 | 0 | 7 | 7 |
| 2025 6 | 7 | 33 | 40 |
| 2025 5 | 172 | 62 | 234 |
| 2025 4 | 134 | 34 | 168 |
| 2025 3 | 177 | 30 | 207 |
| 2025 2 | 145 | 35 | 180 |
| 2025 1 | 110 | 59 | 169 |
| 2024 12 | 88 | 43 | 131 |
| 2024 11 | 121 | 46 | 167 |
| 2024 10 | 77 | 31 | 108 |
| 2024 9 | 97 | 21 | 118 |
| 2024 8 | 94 | 43 | 137 |
| 2024 7 | 98 | 32 | 130 |
| 2024 6 | 109 | 24 | 133 |
| 2024 5 | 93 | 21 | 114 |
| 2024 4 | 117 | 26 | 143 |
| 2024 3 | 133 | 43 | 176 |
| 2024 2 | 78 | 32 | 110 |
| 2024 1 | 126 | 25 | 151 |
| 2023 12 | 102 | 43 | 145 |
| 2023 11 | 132 | 61 | 193 |
| 2023 10 | 147 | 31 | 178 |
| 2023 9 | 107 | 47 | 154 |
| 2023 8 | 149 | 26 | 175 |
| 2023 7 | 94 | 34 | 128 |
| 2023 6 | 103 | 41 | 144 |
| 2023 5 | 78 | 26 | 104 |
| 2023 4 | 75 | 30 | 105 |
| 2023 3 | 104 | 35 | 139 |
| 2023 2 | 106 | 31 | 137 |
| 2023 1 | 126 | 36 | 162 |
| 2022 12 | 141 | 59 | 200 |
| 2022 11 | 134 | 44 | 178 |
| 2022 10 | 162 | 50 | 212 |
| 2022 9 | 184 | 67 | 251 |
| 2022 8 | 115 | 33 | 148 |
| 2022 7 | 101 | 52 | 153 |
| 2022 6 | 111 | 68 | 179 |
| 2022 5 | 85 | 3 | 88 |
| 2022 4 | 101 | 18 | 119 |
| 2022 3 | 223 | 12 | 235 |
| 2022 2 | 433 | 14 | 447 |
| 2022 1 | 488 | 9 | 497 |
| 2021 12 | 386 | 7 | 393 |
| 2021 11 | 122 | 6 | 128 |
| 2021 10 | 196 | 3 | 199 |
| 2021 9 | 111 | 3 | 114 |
| 2021 8 | 123 | 7 | 130 |
| 2021 7 | 91 | 2 | 93 |
| 2021 6 | 121 | 6 | 127 |
| 2021 5 | 602 | 12 | 614 |
| 2021 4 | 1276 | 13 | 1289 |
| 2021 3 | 188 | 7 | 195 |
| 2021 2 | 200 | 3 | 203 |
| 2021 1 | 278 | 18 | 296 |
| 2020 12 | 148 | 21 | 169 |
| 2020 11 | 95 | 22 | 117 |
| 2020 10 | 90 | 14 | 104 |
Show all
